Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-09-05

FDA Approved: ZIPRASIDONE — Original Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved an original application for ziprasidone from Chartwell RX, LLC, enabling a new generic version of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziprasidone (ziprasidone)

Snippet

ORIG AP for ZIPRASIDONE (ZIPRASIDONE)